Colorectal cancer screening.
The CLIA-waived Hemosure[R] Immunochemical Fecal Occult Blood Test (iFOBT) offers a notable consideration in that there are no drug or diet restrictions. It is a rapid, convenient, and odorless test for the determination of human hemoglobin in feces, typically used for colorectal cancer screening. The one-step immunological fecal occult blood test is a qualitative, sandwich dye conjugate immunoassay and employs a unique combination of monoclonal and polyclonal antibodies to selectively identify hemoglobin in test samples with a high degree of sensitivity. In less than five minutes, elevated levels of human hemoglobin as low as 50 ng hHB/ mL can be detected and positive results for high levels of hemoglobin can be seen in the test as early as one or two minutes.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Industry spotligt|
|Publication:||Medical Laboratory Observer|
|Date:||Apr 1, 2012|
|Previous Article:||Reduce the number of false positive test results.|
|Next Article:||John Ledek guides BD's efforts to offer labs innovative solutions for Preanalytical Systems.|